SCHEMBL24486753

SCHEMBL24486753

CCN(CC)CNC(=S)N(C)c1ccccc1

nearest known ligand 0.58

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 3/20 0.58
LMNA P02545 2/20 0.58
ALDH1A1 P00352 4/20 0.49
FAAH O00519 1/20 0.46
PHGDH O43175 1/20 0.46
MGLL Q99685 1/20 0.46
CA12 O43570 1/20 0.46
CA1 P00915 1/20 0.46
CA2 P00918 1/20 0.46
CA9 Q16790 1/20 0.46
MAPT P10636 2/20 0.40
GAA P10253 1/20 0.40
ALOX12 P18054 1/20 0.40
CRHBP P24387 1/20 0.40
HTT P42858 1/20 0.40
CRHR2 Q13324 1/20 0.40
NPSR1 Q6W5P4 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24487125 0.81 PKM (0.45) L3MBTL1LMNAALDH1A1GAAHTT
SCHEMBL11042457 0.75 FAAH (0.48) L3MBTL1LMNAALDH1A1FAAHPHGDH
SCHEMBL6694830 0.74 LMNA (1.00) L3MBTL1LMNAALDH1A1FAAHPHGDH
SCHEMBL3833573 0.72 LMNA (0.68) L3MBTL1LMNAALDH1A1FAAHPHGDH
SCHEMBL1642674 0.72 LMNA (0.68) L3MBTL1LMNAALDH1A1FAAHPHGDH
SCHEMBL24487128 0.71 ALOX12 (0.67) L3MBTL1LMNAALDH1A1MAPTGAA
SCHEMBL24486749 0.71 RECQL (0.41) LMNAALDH1A1CA12CA1CA9
SCHEMBL10394940 0.71 LMNA (0.66) L3MBTL1LMNAALDH1A1FAAHPHGDH
SCHEMBL21533693 0.70 ALDH1A1 (0.45) L3MBTL1LMNAALDH1A1MAPT
SCHEMBL8848450 0.68 FAAH (0.64) L3MBTL1LMNAALDH1A1FAAHPHGDH

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11352325-B2 Rapid fluorescence tagging of glycans and other biomolecules with enhanced MS signals WATERS TECHNOLOGIES CORPORATION (US) 2022-06-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11352325-B2 Rapid fluorescence tagging of glycans and other biomolecules with enhanced MS signals FUT5, FUT6, ST3GAL3 L3MBTL1 2160/4885LMNA 1380/4885ALDH1A1 1650/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.